Interestingly, the urinary levels of VCAM-1 in patients with ANCA-GN, FSGS and membranous nephropathy were not statistically different from the urine levels of VCAM-1 in patients with active LN (Figure 6). This evidence concerns the gene VCAM1 and lobular neoplasia.